{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T18:54:01Z","timestamp":1789498441499,"version":"build-2803163510"},"reference-count":165,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010382","name":"European Society of Endocrinology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010382","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100024012","name":"ESE","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100024012","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,26]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The present report from the ESE Educational Program on Parathyroid Disorders (PARAT Program) presents recent developments and novelties in the clinical care of parathyroid disorders in a question-and-answer format, based on a satellite workshop held in relation to the European Congress of Endocrinology in Stockholm, May 2024. The workshop focused on clinical aspects of 3 main themes: primary hyperparathyroidism (PHPT), chronic hypoparathyroidism (HypoPT) in adults, and parathyroid disorders in pregnancy, with an emphasis on advances since the 2022 PARAT consensus report. The first section focuses on the long-term complications\u2014including fractures, renal impairment, mental health, and quality of life\u2014in patients with asymptomatic or mild forms of PHPT and on treatment strategies for syndromic PHPT (multiple endocrine neoplasia 1-4). In the latter, we explore appropriate surgical and non-surgical approaches, imaging techniques for gland localization, and preservation strategies in cases of multiglandular involvement. The second section addresses transient and partial forms of HypoPT in comparison to chronic and complete parathyroid hormone deficiency. It highlights the potential skeletal consequences of chronic HypoPT, the underlying etiologies, and discusses treatment modifications in light of the evolving therapeutic landscape. The final section, dedicated to the specific considerations of parathyroid disorders during pregnancy and lactation, focuses on pregnancy planning in patients with hereditary syndromic forms of PHPT, the differentiation between parathyroid-related and unrelated causes of hypercalcemia, and the associated risks for both mother and fetus. Additionally, it addresses the practical aspects of managing pregnant women with HypoPT, aiming to provide practical guidance for clinicians. Clinical vignettes featuring 3 cases illustrate common clinical situations.<\/jats:p>","DOI":"10.1093\/ejendo\/lvaf204","type":"journal-article","created":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T12:08:18Z","timestamp":1759320498000},"page":"R65-R88","source":"Crossref","is-referenced-by-count":5,"title":["Advances in the clinical management of parathyroid disorders: report from the 2024 workshop by the ESE educational program on parathyroid disorders"],"prefix":"10.1093","volume":"193","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9833-7960","authenticated-orcid":false,"given":"Lu\u00eds Miguel","family":"Cardoso","sequence":"first","affiliation":[{"name":"Local Health Unity of Coimbra, Coimbra, and I3S\u2013Institute for Research and Innovation in Health, University of Porto , Porto ,","place":["Portugal"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0757-298X","authenticated-orcid":false,"given":"Lars","family":"Rolighed","sequence":"additional","affiliation":[{"name":"Department of Otorhinolaryngology, Head and Neck Surgery, Aarhus University Hospital , 8200 Aarhus N ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0915-085X","authenticated-orcid":false,"given":"Karin","family":"Amrein","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Endocrinology and Diabetology, Medical University of Graz , 8036 Graz ,","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7959-1311","authenticated-orcid":false,"given":"Stefan","family":"Pilz","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Endocrinology and Diabetology, Medical University of Graz , 8036 Graz ,","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Line","family":"Underbjerg","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Internal Medicine, Aarhus University Hospital , 8200 Aarhus N ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikkel","family":"Pretorius","sequence":"additional","affiliation":[{"name":"Section of Endocrinology, Oslo University Hospital , 0372 Oslo ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filomena","family":"Cetani","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, Unit of Endocrinology, University of Pisa , 56126 Pisa ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Zahn","sequence":"additional","affiliation":[{"name":"Department of Endocrine Surgery, Schoen Klinik Hamburg-Eilbek , 22081 Hamburg ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0953-1188","authenticated-orcid":false,"given":"Martin","family":"Almquist","sequence":"additional","affiliation":[{"name":"Department of Surgery, Endocrine-Sarcoma Section, Sk\u00e5ne University Hospital , SE-221 85 Lund ,","place":["Sweden"]},{"name":"Institution of Clinical Sciences Lund, Lund University , SE-221 84 Lund ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6660-6748","authenticated-orcid":false,"given":"Ozer","family":"Makay","sequence":"additional","affiliation":[{"name":"Centre of Endocrine Surgery, Ozel Saglik Hospital, 1399 Sokak, Izmir, T\u00fcrkiye\/Aristotle University, School of Medicine , Thessaloniki ,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Marcocci","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine, University of Pisa , 56126 Pisa ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Rejnmark","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Internal Medicine, Aarhus University Hospital , 8200 Aarhus N ,","place":["Denmark"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heide","family":"Siggelkow","sequence":"additional","affiliation":[{"name":"Department of Trauma, Orthopedics and Reconstructive Surgery, University Medical Center G\u00f6ttingen , 37075 G\u00f6ttingen ,","place":["Germany"]},{"name":"MVZ Endokrinologikum G\u00f6ttingen, Center for Endocrinology, Osteology, Rheumatology, Nuclear Medicine and Human Genetics , 37075 G\u00f6ttingen ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9582-1906","authenticated-orcid":false,"given":"Elena","family":"Tsourdi","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes, and Bone Diseases, Dresden Technical University Medical Center , Dresden 01307 ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1994-4226","authenticated-orcid":false,"given":"Peter","family":"Kamenick\u00fd","sequence":"additional","affiliation":[{"name":"Centre de R\u00e9f\u00e9rence des Maladies Rares de L'Hypophyse , 94270 Le Kremlin-Bic\u00eatre, \u00cele-de-France ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0654-4610","authenticated-orcid":false,"given":"Jens","family":"Bollerslev","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Oslo , 0316 Oslo ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,10,1]]},"reference":[{"issue":"3","key":"2025120106170041600_lvaf204-B1","doi-asserted-by":"publisher","first-page":"P1","DOI":"10.1530\/EJE-19-0316","article-title":"MANAGEMENT OF ENDOCRINE DISEASE: unmet therapeutic, educational and scientific needs in parathyroid disorders","volume":"181","author":"Bollerslev","year":"2019","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"2025120106170041600_lvaf204-B2","doi-asserted-by":"publisher","first-page":"72","DOI":"10.3109\/03009734.2015.1027426","article-title":"The Uppsala anatomist Ivar Sandstrom and the parathyroid gland","volume":"120","author":"Johansson","year":"2015","journal-title":"Ups J Med Sci"},{"issue":"2","key":"2025120106170041600_lvaf204-B3","doi-asserted-by":"publisher","first-page":"R33","DOI":"10.1530\/EJE-21-1044","article-title":"European expert consensus on practical management of specific aspects of parathyroid disorders in adults and in pregnancy: recommendations of the ESE educational program of parathyroid disorders (PARAT 2021)","volume":"186","author":"Bollerslev","year":"2022","journal-title":"Eur J Endocrinol"},{"issue":"12","key":"2025120106170041600_lvaf204-B4","doi-asserted-by":"publisher","first-page":"2663","DOI":"10.1002\/jbmr.4716","article-title":"Management of hypoparathyroidism","volume":"37","author":"Khan","year":"2022","journal-title":"J Bone Miner Res"},{"issue":"6","key":"2025120106170041600_lvaf204-B5","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1210\/jc.2015-3910","article-title":"Management of hypoparathyroidism: present and future","volume":"101","author":"Bilezikian","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2025120106170041600_lvaf204-B6","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1530\/EJE-15-0628","article-title":"European Society of Endocrinology clinical guideline: treatment of chronic hypoparathyroidism in adults","volume":"173","author":"Bollerslev","year":"2015","journal-title":"Eur J Endocrinol"},{"issue":"7","key":"2025120106170041600_lvaf204-B7","doi-asserted-by":"publisher","first-page":"593","DOI":"10.7326\/0003-4819-114-7-593","article-title":"Diagnosis and management of asymptomatic primary hyperparathyroidism: consensus development conference statement","volume":"114","author":"NIH Conference","year":"1991","journal-title":"Ann Intern Med"},{"issue":"11","key":"2025120106170041600_lvaf204-B8","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1002\/jbmr.4677","article-title":"Evaluation and management of primary hyperparathyroidism: summary statement and guidelines from the fifth international workshop","volume":"37","author":"Bilezikian","year":"2022","journal-title":"J Bone Miner Res"},{"issue":"4","key":"2025120106170041600_lvaf204-B9","doi-asserted-by":"publisher","first-page":"101721","DOI":"10.1016\/j.ando.2025.101721","article-title":"Management of primary hyperparathyroidism in MEN1: from initial subtotal surgery to complex treatment of the remaining gland","volume":"86","author":"Schubert","year":"2025","journal-title":"Ann Endocrinol (Paris)"},{"issue":"6","key":"2025120106170041600_lvaf204-B10","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1210\/clinem\/dgac734","article-title":"Approach to the patient: management of parathyroid diseases across pregnancy","volume":"108","author":"Appelman-Dijkstra","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2025120106170041600_lvaf204-B11","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1002\/jbmr.4665","article-title":"Epidemiology, pathophysiology, and genetics of primary hyperparathyroidism","volume":"37","author":"Minisola","year":"2022","journal-title":"J Bone Miner Res"},{"issue":"2","key":"2025120106170041600_lvaf204-B12","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1007\/s00774-017-0833-8","article-title":"Primary hyperparathyroidism: insights from the Indian PHPT registry","volume":"36","author":"Bhadada","year":"2018","journal-title":"J Bone Miner Metab"},{"issue":"6","key":"2025120106170041600_lvaf204-B13","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1007\/s00198-021-05822-9","article-title":"Risk of fractures in primary hyperparathyroidism: a systematic review and meta-analysis","volume":"32","author":"Ejlsmark-Svensson","year":"2021","journal-title":"Osteoporos Int"},{"issue":"3","key":"2025120106170041600_lvaf204-B14","doi-asserted-by":"publisher","first-page":"CD013035","DOI":"10.1002\/14651858.CD013035.pub2","article-title":"Parathyroidectomy for adults with primary hyperparathyroidism","volume":"2023","author":"Pappachan","year":"2023","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"2025120106170041600_lvaf204-B15","doi-asserted-by":"publisher","first-page":"5415","DOI":"10.1210\/jc.2004-0028","article-title":"Randomized controlled clinical trial of surgery versus no surgery in patients with mild asymptomatic primary hyperparathyroidism","volume":"89","author":"Rao","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2025120106170041600_lvaf204-B16","doi-asserted-by":"publisher","first-page":"3114","DOI":"10.1210\/jc.2007-0219","article-title":"Surgery or surveillance for mild asymptomatic primary hyperparathyroidism: a prospective, randomized clinical trial","volume":"92","author":"Ambrogini","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2025120106170041600_lvaf204-B17","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1002\/jbmr.4763","article-title":"Positive effect of parathyroidectomy compared to observation on BMD in a randomized controlled trial of mild primary hyperparathyroidism","volume":"38","author":"Lundstam","year":"2023","journal-title":"J Bone Miner Res"},{"issue":"3","key":"2025120106170041600_lvaf204-B18","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1093\/ejendo\/lvae109","article-title":"No effect of surgery on kidney and cardiovascular risk factors in mild primary hyperparathyroidism: secondary analyses from a 10-year randomized controlled trial","volume":"191","author":"Heck","year":"2024","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"2025120106170041600_lvaf204-B19","doi-asserted-by":"publisher","first-page":"812","DOI":"10.7326\/M21-4416","article-title":"Mortality and morbidity in mild primary hyperparathyroidism: results from a 10-year prospective randomized controlled trial of parathyroidectomy versus observation","volume":"175","author":"Pretorius","year":"2022","journal-title":"Ann Intern Med"},{"issue":"1","key":"2025120106170041600_lvaf204-B20","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1093\/ejendo\/lvad081","article-title":"Long-term effects of primary hyperparathyroidism and parathyroidectomy on kidney function","volume":"189","author":"Zhu","year":"2023","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"2025120106170041600_lvaf204-B21","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1210\/jc.2015-3094","article-title":"Validation of PHPQoL, a disease-specific quality-of-life questionnaire for patients with primary hyperparathyroidism","volume":"101","author":"Webb","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2025120106170041600_lvaf204-B22","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s002689900428","article-title":"Prospective surgical outcome study of relief of symptoms following surgery in patients with primary hyperparathyroidism","volume":"22","author":"Pasieka","year":"1998","journal-title":"World J Surg"},{"issue":"1","key":"2025120106170041600_lvaf204-B23","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s12955-024-02248-9","article-title":"Patient-reported outcome measures for primary hyperparathyroidism: a systematic review of measurement properties","volume":"22","author":"Liang","year":"2024","journal-title":"Health Qual Life Outcomes"},{"issue":"1","key":"2025120106170041600_lvaf204-B24","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/jbmr.4199","article-title":"Effects of parathyroidectomy on quality of life: 10 years of data from a prospective randomized controlled trial on primary hyperparathyroidism (the SIPH-study)","volume":"36","author":"Pretorius","year":"2021","journal-title":"J Bone Miner Res"},{"issue":"4","key":"2025120106170041600_lvaf204-B25","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1530\/EJE-21-0322","article-title":"Postoperative zoledronic acid for osteoporosis in primary hyperparathyroidism: a randomized placebo-controlled study","volume":"185","author":"Ryhanen","year":"2021","journal-title":"Eur J Endocrinol"},{"issue":"11","key":"2025120106170041600_lvaf204-B26","doi-asserted-by":"publisher","first-page":"2351","DOI":"10.1002\/jbmr.4685","article-title":"The efficacy and safety of medical and surgical therapy in patients with primary hyperparathyroidism: a systematic review and meta-analysis of randomized controlled trials","volume":"37","author":"Ye","year":"2022","journal-title":"J Bone Miner Res"},{"key":"2025120106170041600_lvaf204-B27","doi-asserted-by":"publisher","first-page":"e240035","DOI":"10.20945\/2359-4292-2024-0035","article-title":"Rebound hypercalcemia after denosumab cessation during follow-up after surgical treatment for parathyroid carcinoma: case report and literature review","volume":"68","author":"Schmitt","year":"2024","journal-title":"Arch Endocrinol Metab"},{"issue":"1","key":"2025120106170041600_lvaf204-B28","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1186\/s12916-016-0708-1","article-title":"MEN1 redefined, a clinical comparison of mutation-positive and mutation-negative patients","volume":"14","author":"de Laat","year":"2016","journal-title":"BMC Med"},{"issue":"11","key":"2025120106170041600_lvaf204-B29","doi-asserted-by":"publisher","first-page":"e220093","DOI":"10.1530\/EC-22-0093","article-title":"Systematic detection of mosaicism by using digital NGS reveals three new MEN1 mosaicisms","volume":"11","author":"Lagarde","year":"2022","journal-title":"Endocr Connect"},{"issue":"5","key":"2025120106170041600_lvaf204-B30","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"issue":"6","key":"2025120106170041600_lvaf204-B31","doi-asserted-by":"publisher","first-page":"e2271","DOI":"10.1210\/clinem\/dgaa142","article-title":"Clinical MEN-1 among a large cohort of patients with acromegaly","volume":"105","author":"Nachtigall","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2025120106170041600_lvaf204-B32","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1210\/jc.2010-2704","article-title":"The 2011 report on dietary reference intakes for calcium and vitamin D from the institute of medicine: what clinicians need to know","volume":"96","author":"Ross","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2025120106170041600_lvaf204-B33","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s12020-015-0696-5","article-title":"Cinacalcet therapy in patients affected by primary hyperparathyroidism associated to multiple endocrine neoplasia syndrome type 1 (MEN1)","volume":"52","author":"Giusti","year":"2016","journal-title":"Endocrine"},{"issue":"1","key":"2025120106170041600_lvaf204-B34","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1210\/jc.2004-0842","article-title":"Cinacalcet hydrochloride maintains long-term normocalcemia in patients with primary hyperparathyroidism","volume":"90","author":"Peacock","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"2025120106170041600_lvaf204-B35","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1111\/j.1365-2265.2007.02934.x","article-title":"Age-related penetrance of endocrine tumours in multiple endocrine neoplasia type 1 (MEN1): a multicentre study of 258 gene carriers","volume":"67","author":"Machens","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"10","key":"2025120106170041600_lvaf204-B36","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.ciresp.2018.06.014","article-title":"Primary hyperparathyroidism associated with MEN 1: experience in 71 cases","volume":"96","author":"Balsalobre Salmeron","year":"2018","journal-title":"Cir Esp (Engl Ed)"},{"issue":"12","key":"2025120106170041600_lvaf204-B37","doi-asserted-by":"publisher","first-page":"ziae129","DOI":"10.1093\/jbmrpl\/ziae129","article-title":"Bone mineral density over ten years after primary parathyroidectomy in multiple endocrine neoplasia type 1","volume":"8","author":"Kuusela","year":"2024","journal-title":"JBMR Plus"},{"issue":"2","key":"2025120106170041600_lvaf204-B38","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1097\/SLA.0000000000005980","article-title":"Recurrence after surgery for primary hyperparathyroidism in 517 patients with multiple endocrine neoplasia type 1: an association francophone de chirurgie endocrinienne and groupe d'etude des tumeurs endocrines study","volume":"279","author":"Santucci","year":"2024","journal-title":"Ann Surg"},{"issue":"8","key":"2025120106170041600_lvaf204-B39","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/S2213-8587(25)00118-4","article-title":"Treatments for MEN1-associated endocrine tumours: three systematic reviews and a meta-analysis","volume":"13","author":"English","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"9","key":"2025120106170041600_lvaf204-B40","doi-asserted-by":"publisher","first-page":"3113","DOI":"10.3390\/jcm14093113","article-title":"An updated perspective of the clinical features and parathyroidectomy impact in primary hyperparathyroidism amid multiple endocrine neoplasia type 1 (MEN1): focus on bone health","volume":"14","author":"Gheorghe","year":"2025","journal-title":"J Clin Med"},{"issue":"2","key":"2025120106170041600_lvaf204-B41","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1210\/endrev\/bnaa031","article-title":"Multiple endocrine neoplasia type 1: latest insights","volume":"42","author":"Brandi","year":"2021","journal-title":"Endocr Rev"},{"issue":"2","key":"2025120106170041600_lvaf204-B42","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1245\/s10434-015-4865-9","article-title":"Limited parathyroidectomy in multiple endocrine neoplasia type 1-associated primary hyperparathyroidism: a setup for failure","volume":"23","author":"Nilubol","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"11","key":"2025120106170041600_lvaf204-B43","doi-asserted-by":"publisher","first-page":"2666","DOI":"10.1007\/s00268-022-06633-7","article-title":"Less than subtotal parathyroidectomy for multiple endocrine neoplasia type 1 primary hyperparathyroidism: a systematic review and meta-analysis","volume":"46","author":"Bouriez","year":"2022","journal-title":"World J Surg"},{"issue":"8","key":"2025120106170041600_lvaf204-B44","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1007\/s00268-013-2054-1","article-title":"Utility of intraoperative parathyroid hormone monitoring in patients with multiple endocrine neoplasia type 1-associated primary hyperparathyroidism undergoing initial parathyroidectomy","volume":"37","author":"Nilubol","year":"2013","journal-title":"World J Surg"},{"issue":"5","key":"2025120106170041600_lvaf204-B45","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1016\/j.surg.2021.10.046","article-title":"Evaluation of risk factors, long-term outcomes, and immediate and delayed autotransplantation to minimize postsurgical hypoparathyroidism in multiple endocrine neoplasia type 1 (MEN1): a retrospective cohort study","volume":"171","author":"Landry","year":"2022","journal-title":"Surgery"},{"issue":"6","key":"2025120106170041600_lvaf204-B46","doi-asserted-by":"publisher","first-page":"067012","DOI":"10.1117\/1.3583571","article-title":"Near-infrared autofluorescence for the detection of parathyroid glands","volume":"16","author":"Paras","year":"2011","journal-title":"J Biomed Opt"},{"issue":"4","key":"2025120106170041600_lvaf204-B47","doi-asserted-by":"publisher","first-page":"znae075","DOI":"10.1093\/bjs\/znae075","article-title":"Autofluorescence-guided hemithyroidectomy in a low-volume thyroid institution with no experience in parathyroid surgery: randomized clinical trial","volume":"111","author":"Abood","year":"2024","journal-title":"Br J Surg"},{"issue":"11","key":"2025120106170041600_lvaf204-B48","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1001\/jamaoto.2024.3095","article-title":"Near-infrared autofluorescence signatures of single- vs multigland disease in primary hyperparathyroidism","volume":"150","author":"Akgun","year":"2024","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"1","key":"2025120106170041600_lvaf204-B49","doi-asserted-by":"publisher","first-page":"zraa047","DOI":"10.1093\/bjsopen\/zraa047","article-title":"Autofluorescence pattern of parathyroid adenomas","volume":"5","author":"Demarchi","year":"2021","journal-title":"BJS Open"},{"key":"2025120106170041600_lvaf204-B50","doi-asserted-by":"publisher","first-page":"110764","DOI":"10.1016\/j.ijscr.2024.110764","article-title":"Potential benefits of intraoperative parathyroid autofluorescence imaging in a patient with multiple endocrine neoplasia type 1 and hyperparathyroidism\u2014a case report","volume":"126","author":"Egebaek","year":"2025","journal-title":"Int J Surg Case Rep"},{"key":"2025120106170041600_lvaf204-B51","doi-asserted-by":"publisher","first-page":"108878","DOI":"10.1016\/j.surg.2024.05.062","article-title":"Parathyroid near-infrared autofluorescence use for parathyroidectomy in mild primary hyperparathyroidism: results from a randomized monocentric trial","volume":"177","author":"Frey","year":"2025","journal-title":"Surgery"},{"issue":"10","key":"2025120106170041600_lvaf204-B52","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1001\/jamaoto.2019.1987","article-title":"Intraoperative autofluorescence parathyroid identification in patients with multiple endocrine neoplasia type 1","volume":"145","author":"Squires","year":"2019","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"18","key":"2025120106170041600_lvaf204-B53","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1056\/NEJMcp1800213","article-title":"Hypoparathyroidism","volume":"380","author":"Gafni","year":"2019","journal-title":"N Engl J Med"},{"issue":"12","key":"2025120106170041600_lvaf204-B54","doi-asserted-by":"publisher","first-page":"2568","DOI":"10.1002\/jbmr.4691","article-title":"Evaluation and management of hypoparathyroidism summary statement and guidelines from the second international workshop","volume":"37","author":"Khan","year":"2022","journal-title":"J Bone Miner Res"},{"issue":"3","key":"2025120106170041600_lvaf204-B55","doi-asserted-by":"publisher","first-page":"e00269","DOI":"10.1002\/edm2.269","article-title":"Changes in treatment needs for chronic postoperative hypoparathyroidism during initiation of conventional treatment compared to stable phase of treatment","volume":"4","author":"Storm","year":"2021","journal-title":"Endocrinol Diabetes Metab"},{"issue":"6","key":"2025120106170041600_lvaf204-B56","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1172\/JCI108424","article-title":"Comparison of effects of 1 alpha-hydroxy-vitamin D3 and 1,25-dihydroxy-vitamin D3 in man","volume":"57","author":"Brickman","year":"1976","journal-title":"J Clin Invest"},{"issue":"7","key":"2025120106170041600_lvaf204-B57","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1210\/clinem\/dgab114","article-title":"Alfacalcidol vs calcitriol in the management of patient with hypoparathyroidism: a randomized controlled trial","volume":"106","author":"Saha","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2025120106170041600_lvaf204-B58","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1007\/s40200-023-01292-4","article-title":"Assessment of quality of life in patients with permanent hypoparathyroidism receiving conventional treatment","volume":"22","author":"Cherchir","year":"2023","journal-title":"J Diabetes Metab Disord"},{"issue":"4","key":"2025120106170041600_lvaf204-B59","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/j.ecl.2018.07.010","article-title":"Quality of life in hypoparathyroidism","volume":"47","author":"Vokes","year":"2018","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"12","key":"2025120106170041600_lvaf204-B60","doi-asserted-by":"publisher","first-page":"2642","DOI":"10.1002\/jbmr.4673","article-title":"Complications, symptoms, presurgical predictors in patients with chronic hypoparathyroidism: a systematic review","volume":"37","author":"Yao","year":"2022","journal-title":"J Bone Miner Res"},{"issue":"9","key":"2025120106170041600_lvaf204-B61","doi-asserted-by":"publisher","first-page":"4214","DOI":"10.1210\/jc.2002-021736","article-title":"Long-term treatment of hypoparathyroidism: a randomized controlled study comparing parathyroid hormone-(1-34) versus calcitriol and calcium","volume":"88","author":"Winer","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2025120106170041600_lvaf204-B62","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1002\/jbmr.3824","article-title":"Design and preclinical development of TransCon PTH, an investigational sustained-release PTH replacement therapy for hypoparathyroidism","volume":"34","author":"Holten-Andersen","year":"2019","journal-title":"J Bone Miner Res"},{"issue":"1","key":"2025120106170041600_lvaf204-B63","doi-asserted-by":"publisher","first-page":"e372","DOI":"10.1210\/clinem\/dgab577","article-title":"PaTH forward: a randomized, double-blind, placebo-controlled phase 2 trial of TransCon PTH in adult hypoparathyroidism","volume":"107","author":"Khan","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2025120106170041600_lvaf204-B64","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/jbmr.4726","article-title":"Efficacy and safety of parathyroid hormone replacement with TransCon PTH in hypoparathyroidism: 26-week results from the phase 3 PaTHway trial","volume":"38","author":"Khan","year":"2023","journal-title":"J Bone Miner Res"},{"issue":"11","key":"2025120106170041600_lvaf204-B65","doi-asserted-by":"publisher","first-page":"3308","DOI":"10.1210\/jc.2011-1359","article-title":"Long-term results of continuous subcutaneous recombinant PTH (1-34) infusion in children with refractory hypoparathyroidism","volume":"96","author":"Linglart","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"2025120106170041600_lvaf204-B66","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1210\/clinem\/dgae121","article-title":"An open-label phase 2 study of eneboparatide, a novel PTH receptor 1 agonist, in hypoparathyroidism","volume":"109","author":"Takacs","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"2025120106170041600_lvaf204-B67","doi-asserted-by":"publisher","first-page":"bvaf113","DOI":"10.1210\/jendso\/bvaf113","article-title":"Switch from rhPTH1-84 to TransCon PTH with individual dose adjustment in adult hypoparathyroidism-4-week results","volume":"9","author":"Siggelkow","year":"2025","journal-title":"J Endocr Soc"},{"issue":"4","key":"2025120106170041600_lvaf204-B68","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/S2213-8587(13)70106-2","article-title":"Efficacy and safety of recombinant human parathyroid hormone (1-84) in hypoparathyroidism (REPLACE): a double-blind, placebo-controlled, randomised, phase 3 study","volume":"1","author":"Mannstadt","year":"2013","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"11","key":"2025120106170041600_lvaf204-B69","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1002\/jbmr.2555","article-title":"Transient increased calcium and calcitriol requirements after discontinuation of human synthetic parathyroid hormone 1-34 (hPTH 1-34) replacement therapy in hypoparathyroidism","volume":"30","author":"Gafni","year":"2015","journal-title":"J Bone Miner Res"},{"issue":"4","key":"2025120106170041600_lvaf204-B70","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1210\/clinem\/dgae693","article-title":"Efficacy and safety of TransCon PTH in adults with hypoparathyroidism: 52-week results from the phase 3 PaTHway trial","volume":"110","author":"Clarke","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2025120106170041600_lvaf204-B71","doi-asserted-by":"publisher","first-page":"e66551","DOI":"10.7759\/cureus.66551","article-title":"Risk factors for transient and permanent hypoparathyroidism following thyroidectomy: a comprehensive review","volume":"16","author":"Maheshwari","year":"2024","journal-title":"Cureus"},{"issue":"S1","key":"2025120106170041600_lvaf204-B72","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.21037\/gs.2017.10.04","article-title":"A nomogram to predict the likelihood of permanent hypoparathyroidism after total thyroidectomy based on delayed serum calcium and iPTH measurements","volume":"6","author":"Sitges-Serra","year":"2017","journal-title":"Gland Surg"},{"issue":"6","key":"2025120106170041600_lvaf204-B73","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/j.surg.2012.08.030","article-title":"Predicting the need for calcium and calcitriol supplementation after total thyroidectomy: results of a prospective, randomized study","volume":"152","author":"Cayo","year":"2012","journal-title":"Surgery"},{"issue":"7","key":"2025120106170041600_lvaf204-B74","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1007\/s00268-019-04987-z","article-title":"Hypoparathyroidism after total thyroidectomy: importance of the intraoperative management of the parathyroid glands","volume":"43","author":"Ponce de Leon-Ballesteros","year":"2019","journal-title":"World J Surg"},{"issue":"1","key":"2025120106170041600_lvaf204-B75","doi-asserted-by":"publisher","first-page":"82","DOI":"10.3978\/j.issn.2227-684X.2014.12.04","article-title":"Defining the syndromes of parathyroid failure after total thyroidectomy","volume":"4","author":"Lorente-Poch","year":"2015","journal-title":"Gland Surg"},{"issue":"8","key":"2025120106170041600_lvaf204-B76","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1007\/s00268-012-1574-4","article-title":"Risk factors for medically treated hypocalcemia after surgery for graves\u2019 disease: a Swedish multicenter study of 1,157 patients","volume":"36","author":"Hallgrimsson","year":"2012","journal-title":"World J Surg"},{"issue":"1","key":"2025120106170041600_lvaf204-B77","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1007\/s12020-019-01858-4","article-title":"Huge variations in definition and reported incidence of postsurgical hypoparathyroidism: a systematic review","volume":"64","author":"Harslof","year":"2019","journal-title":"Endocrine"},{"issue":"12","key":"2025120106170041600_lvaf204-B78","doi-asserted-by":"publisher","first-page":"2586","DOI":"10.1002\/jbmr.4714","article-title":"Etiology and pathophysiology of hypoparathyroidism: a narrative review","volume":"37","author":"Pasieka","year":"2022","journal-title":"J Bone Miner Res"},{"issue":"1","key":"2025120106170041600_lvaf204-B79","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1186\/1477-7819-12-200","article-title":"Relationship between hypoparathyroidism and the number of parathyroid glands preserved during thyroidectomy","volume":"12","author":"Song","year":"2014","journal-title":"World J Surg Oncol"},{"issue":"4","key":"2025120106170041600_lvaf204-B80","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1002\/bjs.9676","article-title":"Importance of in situ preservation of parathyroid glands during total thyroidectomy","volume":"102","author":"Lorente-Poch","year":"2015","journal-title":"Br J Surg"},{"issue":"12","key":"2025120106170041600_lvaf204-B81","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1055\/s-0042-118181","article-title":"Long-term follow-up and treatment of postoperative permanent hypoparathyroidism in patients with medullary thyroid carcinoma: differences in complete and partial disease","volume":"48","author":"Leidig-Bruckner","year":"2016","journal-title":"Horm Metab Res"},{"issue":"1","key":"2025120106170041600_lvaf204-B82","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/s13023-024-03155-4","article-title":"Economic burden of patients with post-surgical chronic and transient hypoparathyroidism in the United States examined using insurance claims data","volume":"19","author":"Deering","year":"2024","journal-title":"Orphanet J Rare Dis"},{"issue":"4","key":"2025120106170041600_lvaf204-B83","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1210\/clinem\/dgab039","article-title":"Preoperative vitamin D deficiency is a risk factor for postthyroidectomy hypoparathyroidism: a systematic review and meta-analysis of observational studies","volume":"106","author":"Vaitsi","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2025120106170041600_lvaf204-B84","doi-asserted-by":"publisher","first-page":"bvac174","DOI":"10.1210\/jendso\/bvac174","article-title":"Vitamin D deficiency reduces postthyroidectomy protracted hypoparathyroidism risk. Is gland preconditioning possible?","volume":"7","author":"Martin-Roman","year":"2022","journal-title":"J Endocr Soc"},{"key":"2025120106170041600_lvaf204-B85","doi-asserted-by":"publisher","first-page":"401","DOI":"10.2310\/7070.2012.00053","article-title":"Vitamin D deficiency and the risk of hypocalcemia following total thyroidectomy","volume":"41","author":"Nhan","year":"2012","journal-title":"J Otolaryngol Head Neck Surg"},{"issue":"5","key":"2025120106170041600_lvaf204-B86","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1007\/s00268-005-7729-9","article-title":"Parathyroid autotransplantation during total thyroidectomy\u2013does the number of glands transplanted affect outcome?","volume":"29","author":"Palazzo","year":"2005","journal-title":"World J Surg"},{"issue":"1","key":"2025120106170041600_lvaf204-B87","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1002\/jso.2930460106","article-title":"Parathyroid autotransplantation during thyroid surgery","volume":"46","author":"Shaha","year":"1991","journal-title":"J Surg Oncol"},{"issue":"11","key":"2025120106170041600_lvaf204-B88","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1046\/j.1440-1622.1999.01697.x","article-title":"Routine autotransplantation of at least one parathyroid gland during total thyroidectomy may reduce permanent hypoparathyroidism to zero","volume":"69","author":"Zedenius","year":"1999","journal-title":"Aust N Z J Surg"},{"issue":"7","key":"2025120106170041600_lvaf204-B89","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1111\/j.1445-2197.2005.03435.x","article-title":"Recovery of parathyroid function after total thyroidectomy: long-term follow-up study","volume":"75","author":"Kihara","year":"2005","journal-title":"ANZ J Surg"},{"issue":"5","key":"2025120106170041600_lvaf204-B90","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1159\/000470840","article-title":"Prolonged duration of surgery predicts postoperative hypoparathyroidism among patients undergoing total thyroidectomy in a tertiary referral centre","volume":"6","author":"Sonne-Holm","year":"2017","journal-title":"Eur Thyroid J"},{"issue":"39","key":"2025120106170041600_lvaf204-B91","doi-asserted-by":"publisher","first-page":"e8162","DOI":"10.1097\/MD.0000000000008162","article-title":"Risk factors of hypoparathyroidism following total thyroidectomy with central lymph node dissection","volume":"96","author":"Su","year":"2017","journal-title":"Medicine (Baltimore)"},{"issue":"8","key":"2025120106170041600_lvaf204-B92","doi-asserted-by":"publisher","first-page":"e0221173","DOI":"10.1371\/journal.pone.0221173","article-title":"The effectiveness of parathyroid gland autotransplantation in preserving parathyroid function during thyroid surgery for thyroid neoplasms: a meta-analysis","volume":"14","author":"Wang","year":"2019","journal-title":"PLoS One"},{"issue":"6","key":"2025120106170041600_lvaf204-B93","doi-asserted-by":"publisher","first-page":"3827","DOI":"10.1097\/JS9.0000000000001247","article-title":"The impact of using near-infrared autofluorescence on parathyroid gland parameters and clinical outcomes during total thyroidectomy: a meta-analytic study of randomized controlled trials","volume":"110","author":"Safia","year":"2024","journal-title":"Int J Surg"},{"issue":"2","key":"2025120106170041600_lvaf204-B94","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/8756-3282(95)00443-2","article-title":"Bone histomorphometry in hypoparathyroid patients treated with vitamin D","volume":"18","author":"Langdahl","year":"1996","journal-title":"Bone"},{"issue":"2","key":"2025120106170041600_lvaf204-B95","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1002\/jbmr.2609","article-title":"Noninvasive assessment of skeletal microstructure and estimated bone strength in hypoparathyroidism","volume":"31","author":"Cusano","year":"2016","journal-title":"J Bone Miner Res"},{"issue":"7","key":"2025120106170041600_lvaf204-B96","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1002\/jbmr.4005","article-title":"Changes in skeletal microstructure through four continuous years of rhPTH(1-84) therapy in hypoparathyroidism","volume":"35","author":"Cusano","year":"2020","journal-title":"J Bone Miner Res"},{"issue":"3","key":"2025120106170041600_lvaf204-B97","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1002\/jbmr.3328","article-title":"Bone status among patients with nonsurgical hypoparathyroidism, autosomal dominant hypocalcaemia, and pseudohypoparathyroidism: a cohort study","volume":"33","author":"Underbjerg","year":"2018","journal-title":"J Bone Miner Res"},{"issue":"3","key":"2025120106170041600_lvaf204-B98","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1359\/JBMR.051109","article-title":"A novel tetracycline labeling schedule for longitudinal evaluation of the short-term effects of anabolic therapy with a single iliac crest bone biopsy: early actions of teriparatide","volume":"21","author":"Lindsay","year":"2006","journal-title":"J Bone Miner Res"},{"issue":"4","key":"2025120106170041600_lvaf204-B99","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1359\/jbmr.070104","article-title":"Effects of a one-month treatment with PTH(1-34) on bone formation on cancellous, endocortical, and periosteal surfaces of the human ilium","volume":"22","author":"Lindsay","year":"2007","journal-title":"J Bone Miner Res"},{"issue":"11","key":"2025120106170041600_lvaf204-B100","doi-asserted-by":"publisher","first-page":"2727","DOI":"10.1002\/jbmr.452","article-title":"PTH(1-84) administration reverses abnormal bone-remodeling dynamics and structure in hypoparathyroidism","volume":"26","author":"Rubin","year":"2011","journal-title":"J Bone Miner Res"},{"issue":"4","key":"2025120106170041600_lvaf204-B101","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1002\/jbmr.4780","article-title":"The clinical and skeletal effects of long-term therapy of hypoparathyroidism with rhPTH(1-84)","volume":"38","author":"Agarwal","year":"2023","journal-title":"J Bone Miner Res"},{"issue":"5","key":"2025120106170041600_lvaf204-B102","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1210\/clinem\/dgab076","article-title":"Vertebral fracture assessment in postmenopausal women with postsurgical hypoparathyroidism","volume":"106","author":"Cipriani","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2025120106170041600_lvaf204-B103","doi-asserted-by":"publisher","first-page":"5795","DOI":"10.1210\/jc.2019-00698","article-title":"Predictors of poor bone microarchitecture assessed by trabecular bone score in postsurgical hypoparathyroidism","volume":"104","author":"Sakane","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2025120106170041600_lvaf204-B104","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s00198-019-05177-2","article-title":"PTH and bone material strength in hypoparathyroidism as measured by impact microindentation","volume":"31","author":"Starr","year":"2020","journal-title":"Osteoporos Int"},{"issue":"9","key":"2025120106170041600_lvaf204-B105","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1007\/s40618-022-01818-2","article-title":"Vertebral fractures, trabecular bone score and their determinants in chronic hypoparathyroidism","volume":"45","author":"Saha","year":"2022","journal-title":"J Endocrinol Invest"},{"issue":"5","key":"2025120106170041600_lvaf204-B106","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1002\/jbmr.2734","article-title":"A meta-analysis of trabecular bone score in fracture risk prediction and its relationship to FRAX","volume":"31","author":"McCloskey","year":"2016","journal-title":"J Bone Miner Res"},{"issue":"2","key":"2025120106170041600_lvaf204-B107","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1111\/cen.13895","article-title":"Increased mortality and morbidity in patients with chronic hypoparathyroidism: a population-based study","volume":"90","author":"Vadiveloo","year":"2019","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"11","key":"2025120106170041600_lvaf204-B108","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.1002\/jbmr.2273","article-title":"Postsurgical hypoparathyroidism\u2013risk of fractures, psychiatric diseases, cancer, cataract, and infections","volume":"29","author":"Underbjerg","year":"2014","journal-title":"J Bone Miner Res"},{"issue":"7","key":"2025120106170041600_lvaf204-B109","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1093\/jbmr\/zjaf061","article-title":"Increased risk of vertebral fractures and reduced risk of femur fractures in patients with chronic hypoparathyroidism: a nationwide cohort study in Sweden","volume":"40","author":"Bjornsdottir","year":"2025","journal-title":"J Bone Miner Res"},{"issue":"9","key":"2025120106170041600_lvaf204-B110","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1002\/jbmr.2501","article-title":"The epidemiology of nonsurgical hypoparathyroidism in Denmark: a nationwide case finding study","volume":"30","author":"Underbjerg","year":"2015","journal-title":"J Bone Miner Res"},{"issue":"3","key":"2025120106170041600_lvaf204-B111","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1002\/jbmr.3329","article-title":"A population-based study of the epidemiology of chronic hypoparathyroidism","volume":"33","author":"Vadiveloo","year":"2018","journal-title":"J Bone Miner Res"},{"issue":"7","key":"2025120106170041600_lvaf204-B112","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1210\/jcem.80.7.7608266","article-title":"Attenuation of postmenopausal high turnover bone loss in patients with hypoparathyroidism","volume":"80","author":"Fujiyama","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2025120106170041600_lvaf204-B113","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1472-6823-13-1","article-title":"Increased vertebral morphometric fracture in patients with postsurgical hypoparathyroidism despite normal bone mineral density","volume":"13","author":"Mendonca","year":"2013","journal-title":"BMC Endocr Disord"},{"issue":"1","key":"2025120106170041600_lvaf204-B114","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1210\/jc.2016-3292","article-title":"Vertebral fractures and bone mineral density in patients with idiopathic hypoparathyroidism on long-term follow-up","volume":"102","author":"Chawla","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2025120106170041600_lvaf204-B115","doi-asserted-by":"publisher","first-page":"e0232842","DOI":"10.1371\/journal.pone.0232842","article-title":"Prevalence and complications of nonsurgical hypoparathyroidism in Korea: a nationwide cohort study","volume":"15","author":"Kim","year":"2020","journal-title":"PLoS One"},{"issue":"4","key":"2025120106170041600_lvaf204-B116","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/j.surg.2018.10.034","article-title":"Trabecular bone score and bone mineral density in patients with postsurgical hypoparathyroidism after total thyroidectomy for differentiated thyroid carcinoma","volume":"165","author":"Iglesias","year":"2019","journal-title":"Surgery"},{"issue":"6","key":"2025120106170041600_lvaf204-B117","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1007\/s00198-014-2677-6","article-title":"Effects of PTH(1-84) therapy on muscle function and quality of life in hypoparathyroidism: results from a randomized controlled trial","volume":"25","author":"Sikjaer","year":"2014","journal-title":"Osteoporos Int"},{"issue":"2","key":"2025120106170041600_lvaf204-B118","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1152\/physrev.00027.2015","article-title":"Maternal mineral and bone metabolism during pregnancy, lactation, and post-weaning recovery","volume":"96","author":"Kovacs","year":"2016","journal-title":"Physiol Rev"},{"issue":"12","key":"2025120106170041600_lvaf204-B119","doi-asserted-by":"publisher","first-page":"e1642","DOI":"10.1210\/clinem\/dgad340","article-title":"Abnormal calcium levels are associated with worse maternal and fetal outcomes; results from an exploratory study","volume":"108","author":"Arshad","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2025120106170041600_lvaf204-B120","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1210\/jc.2015-1110","article-title":"Pregnancy outcomes in women with primary hyperparathyroidism","volume":"100","author":"Hirsch","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2025120106170041600_lvaf204-B121","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1111\/j.1365-2265.2008.03495.x","article-title":"Hyperparathyroidism during pregnancy and the effect of rising calcium on pregnancy loss: a call for earlier intervention","volume":"71","author":"Norman","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"2025120106170041600_lvaf204-B122","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s12020-024-03930-0","article-title":"Comparison between surgical and non-surgical management of primary hyperparathyroidism during pregnancy: a systematic review","volume":"86","author":"Eli","year":"2024","journal-title":"Endocrine"},{"key":"2025120106170041600_lvaf204-B123","doi-asserted-by":"publisher","first-page":"105611","DOI":"10.1016\/j.jsbmb.2020.105611","article-title":"Gestational hypercalcemia: prevalence and biochemical profile","volume":"199","author":"Schoenmakers","year":"2020","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"12","key":"2025120106170041600_lvaf204-B124","doi-asserted-by":"publisher","first-page":"4417","DOI":"10.1210\/jc.2017-01617","article-title":"Parathyroid hormone-related protein-induced hypercalcemia of pregnancy successfully reversed by a dopamine agonist","volume":"102","author":"Winter","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2025120106170041600_lvaf204-B125","doi-asserted-by":"publisher","first-page":"e10362","DOI":"10.1002\/jbm4.10362","article-title":"Familial hypocalciuric hypercalcemia in pregnancy: diagnostic pitfalls","volume":"4","author":"Jones","year":"2020","journal-title":"JBMR Plus"},{"issue":"12","key":"2025120106170041600_lvaf204-B126","doi-asserted-by":"publisher","first-page":"2518","DOI":"10.3390\/nu14122518","article-title":"Hypercalcemia in pregnancy due to CYP24A1 mutations: case report and review of the literature","volume":"14","author":"Pilz","year":"2022","journal-title":"Nutrients"},{"issue":"8","key":"2025120106170041600_lvaf204-B127","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1007\/s00228-024-03693-7","article-title":"Does the use of bisphosphonates during pregnancy affect fetal outcomes? A systematic review","volume":"80","author":"de Campos","year":"2024","journal-title":"Eur J Clin Pharmacol"},{"issue":"2","key":"2025120106170041600_lvaf204-B128","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4172\/2161-0509.1000189","article-title":"Effects of Denosumab treatment during early pregnancy: a case report","volume":"6","author":"Isobe","year":"2015","journal-title":"J Nutr Disord Ther."},{"issue":"8","key":"2025120106170041600_lvaf204-B129","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1002\/lary.29489","article-title":"Primary hyperparathyroidism during pregnancy treated with parathyroidectomy: a systematic review","volume":"131","author":"Sandler","year":"2021","journal-title":"Laryngoscope"},{"issue":"7","key":"2025120106170041600_lvaf204-B130","doi-asserted-by":"publisher","first-page":"luae117","DOI":"10.1210\/jcemcr\/luae117","article-title":"Use of cinacalcet for the management of primary hyperparathyroidism in pregnancy","volume":"2","author":"Foster","year":"2024","journal-title":"JCEM Case Rep"},{"issue":"4","key":"2025120106170041600_lvaf204-B131","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1177\/003591573102400461","article-title":"Hyperparathyroidism: generalized osteitis Fibrosa with multiple osteoclastomata","volume":"24","author":"Hunter","year":"1931","journal-title":"Proc R Soc Med"},{"issue":"1","key":"2025120106170041600_lvaf204-B132","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/s0002-9610(98)00302-x","article-title":"Hyperparathyroidism and pregnancy","volume":"177","author":"Kort","year":"1999","journal-title":"Am J Surg"},{"issue":"6","key":"2025120106170041600_lvaf204-B133","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1111\/joim.12523","article-title":"Genetics of parathyroid tumours","volume":"280","author":"Thakker","year":"2016","journal-title":"J Intern Med"},{"issue":"1","key":"2025120106170041600_lvaf204-B134","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s42000-023-00508-9","article-title":"Genetics of hereditary forms of primary hyperparathyroidism","volume":"23","author":"English","year":"2024","journal-title":"Hormones (Athens)"},{"issue":"5","key":"2025120106170041600_lvaf204-B135","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1210\/endrev\/bnad009","article-title":"Molecular and clinical spectrum of primary hyperparathyroidism","volume":"44","author":"Jha","year":"2023","journal-title":"Endocr Rev"},{"issue":"4","key":"2025120106170041600_lvaf204-B136","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1007\/BF02599166","article-title":"Hyperparathyroidism and pregnancy: case report and review","volume":"7","author":"Carella","year":"1992","journal-title":"J Gen Intern Med"},{"issue":"1","key":"2025120106170041600_lvaf204-B137","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1097\/OGX.0000000000000977","article-title":"Hyperparathyroidism in pregnancy: a review of the literature","volume":"77","author":"Strebeck","year":"2022","journal-title":"Obstet Gynecol Surv"},{"key":"2025120106170041600_lvaf204-B138","doi-asserted-by":"publisher","first-page":"19-0039","DOI":"10.1530\/EDM-19-0039","article-title":"Management of primary hyperparathyroidism in pregnancy: a case series","volume":"2019","author":"McCarthy","year":"2019","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"2025120106170041600_lvaf204-B139","doi-asserted-by":"publisher","first-page":"20-0130","DOI":"10.1530\/EDM-20-0130","article-title":"Primary hyperparathyroidism and Zollinger Ellison syndrome during pregnancy: a case report","volume":"2021","author":"Ali","year":"2021","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"issue":"11","key":"2025120106170041600_lvaf204-B140","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.4158\/EP-2019-0035","article-title":"Primary hyperparathyroidism during pregnancy: a case series of 8 patients","volume":"25","author":"Song","year":"2019","journal-title":"Endocr Pract"},{"issue":"1","key":"2025120106170041600_lvaf204-B141","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1186\/s12902-022-01169-2","article-title":"Parathyroid carcinoma during pregnancy: a novel pathogenic CDC73 mutation\u2014a case report","volume":"22","author":"Dematapitiya","year":"2022","journal-title":"BMC Endocr Disord"},{"issue":"12","key":"2025120106170041600_lvaf204-B142","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1002\/humu.23337","article-title":"Molecular genetics of syndromic and non-syndromic forms of parathyroid carcinoma","volume":"38","author":"Cardoso","year":"2017","journal-title":"Hum Mutat"},{"key":"2025120106170041600_lvaf204-B143","doi-asserted-by":"publisher","first-page":"EP187","DOI":"10.1530\/endoabs.90.EP187","article-title":"Hyperparathyroidism jaw tumour syndrome in pregnancy: a rare coexistence","volume":"90","author":"Lopes","year":"2023","journal-title":"Endocrine Abstracts"},{"issue":"9","key":"2025120106170041600_lvaf204-B144","doi-asserted-by":"publisher","first-page":"2990","DOI":"10.1210\/jc.2012-1230","article-title":"Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1)","volume":"97","author":"Thakker","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2025120106170041600_lvaf204-B145","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/humu.20605","article-title":"Multiple endocrine neoplasia type 1 (MEN1): analysis of 1336 mutations reported in the first decade following identification of the gene","volume":"29","author":"Lemos","year":"2008","journal-title":"Hum Mutat"},{"issue":"12","key":"2025120106170041600_lvaf204-B146","doi-asserted-by":"publisher","first-page":"4534","DOI":"10.1210\/jc.2017-01249","article-title":"CDC73-related disorders: clinical manifestations and case detection in primary hyperparathyroidism","volume":"102","author":"van der Tuin","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2025120106170041600_lvaf204-B147","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.beem.2018.05.004","article-title":"Familial hypocalciuric hypercalcemia and related disorders","volume":"32","author":"Lee","year":"2018","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"2025120106170041600_lvaf204-B148","doi-asserted-by":"publisher","first-page":"2725486","DOI":"10.1155\/2016\/2725486","article-title":"The biochemical profile of familial hypocalciuric hypercalcemia and primary hyperparathyroidism during pregnancy and lactation: two case reports and review of the literature","volume":"2016","author":"Ghaznavi","year":"2016","journal-title":"Case Rep Endocrinol"},{"issue":"3","key":"2025120106170041600_lvaf204-B149","doi-asserted-by":"publisher","first-page":"158","DOI":"10.3978\/j.issn.2227-684X.2014.02.04","article-title":"Parathyroidectomy in pregnancy\u2014a single centre experience with review of evidence and proposal for treatment algorithim","volume":"3","author":"Walker","year":"2014","journal-title":"Gland Surg"},{"issue":"10","key":"2025120106170041600_lvaf204-B150","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1002\/ccr3.1074","article-title":"Making (mis) sense of asymptomatic marked hypercalcemia in pregnancy","volume":"5","author":"Maltese","year":"2017","journal-title":"Clin Case Rep"},{"key":"2025120106170041600_lvaf204-B151","first-page":"P16","article-title":"Familial hypocalciuric hypercalcaemia and pregnancy outcome. Presented at society for endocrinology BES 2009","volume":"19","author":"Murthy","year":"2009","journal-title":"Endocr Abst"},{"issue":"5","key":"2025120106170041600_lvaf204-B152","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1210\/clinem\/dgae409","article-title":"Fertility and pregnancy outcomes in primary hyperparathyroidism: observations from a large insured population","volume":"110","author":"Sant","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2025120106170041600_lvaf204-B153","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1186\/s12902-021-00888-2","article-title":"The PARADIGHM (physicians advancing disease knowledge in hypoparathyroidism) registry for patients with chronic hypoparathyroidism: study protocol and interim baseline patient characteristics","volume":"21","author":"Gittoes","year":"2021","journal-title":"BMC Endocr Disord"},{"issue":"9","key":"2025120106170041600_lvaf204-B154","doi-asserted-by":"publisher","first-page":"807","DOI":"10.3109\/09513590.2013.813473","article-title":"The effect of continuous subcutaneous recombinant PTH (1-34) infusion during pregnancy on calcium homeostasis\u2014a case report","volume":"29","author":"Ilany","year":"2013","journal-title":"Gynecol Endocrinol"},{"issue":"5","key":"2025120106170041600_lvaf204-B155","doi-asserted-by":"publisher","first-page":"bvac031","DOI":"10.1210\/jendso\/bvac031","article-title":"Subcutaneous infusion of rhPTH(1-34) during pregnancy and nursing in a woman with autosomal dominant hypoparathyroidism 1","volume":"6","author":"Shulman","year":"2022","journal-title":"J Endocr Soc"},{"issue":"2","key":"2025120106170041600_lvaf204-B156","doi-asserted-by":"publisher","first-page":"22-0401","DOI":"10.1530\/EDM-22-0401","article-title":"Use of rhPTH(1-84) for hypoparathyroidism during early pregnancy and lactation","volume":"2023","author":"Liao","year":"2023","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"issue":"3","key":"2025120106170041600_lvaf204-B157","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1530\/eje.0.1390284","article-title":"Management of hypoparathyroidism during pregnancy\u2014report of twelve cases","volume":"139","author":"Callies","year":"1998","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"2025120106170041600_lvaf204-B158","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1186\/s13023-021-02053-3","article-title":"Hypoparathyroidism and pseudohypoparathyroidism in pregnancy: an Italian retrospective observational study","volume":"16","author":"Marcucci","year":"2021","journal-title":"Orphanet J Rare Dis"},{"issue":"11","key":"2025120106170041600_lvaf204-B159","doi-asserted-by":"publisher","first-page":"3312","DOI":"10.1210\/clinem\/dgab503","article-title":"Women with chronic hypoparathyroidism have low risk of adverse pregnancy outcomes","volume":"106","author":"Bjornsdottir","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2025120106170041600_lvaf204-B160","doi-asserted-by":"publisher","first-page":"e528","DOI":"10.1210\/clinem\/dgab705","article-title":"Pregnancy outcome in women with APECED (APS-1): a multicenter study on 43 females with 83 pregnancies","volume":"107","author":"Laakso","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2025120106170041600_lvaf204-B161","doi-asserted-by":"publisher","first-page":"323","DOI":"10.5505\/ktd.2021.34270","article-title":"Hypoparathyroid pregnancy: retrospective analysis of twenty cases","volume":"10","author":"Topalo\u011flu","year":"2021","journal-title":"Kocaeli Med J"},{"key":"2025120106170041600_lvaf204-B162","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.bonr.2015.05.005","article-title":"Management of hypoparathyroidism in pregnancy and lactation\u2014a report of 10 cases","volume":"3","author":"Hatswell","year":"2015","journal-title":"Bone Rep"},{"issue":"3","key":"2025120106170041600_lvaf204-B163","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1111\/cen.14212","article-title":"Changes in treatment needs of hypoparathyroidism during pregnancy and lactation: a case series","volume":"93","author":"Hartogsohn","year":"2020","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"2025120106170041600_lvaf204-B164","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1007\/s00223-021-00908-2","article-title":"Identifying clinical characteristics of hypoparathyroidism in Turkey: HIPOPARATURK-NET study","volume":"110","author":"Degertekin C","year":"2022","journal-title":"Calcif Tissue Int"},{"issue":"Supplement_2","key":"2025120106170041600_lvaf204-B165","doi-asserted-by":"publisher","first-page":"ii23","DOI":"10.1093\/ejendo\/lvaf064","article-title":"EndoCompass project: research roadmap for calcium and bone endocrinology","volume":"193","author":"Jahn-Rickert","year":"2025","journal-title":"Eur J Endocrinol"}],"container-title":["European Journal of Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ejendo\/advance-article-pdf\/doi\/10.1093\/ejendo\/lvaf204\/64465164\/lvaf204.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/193\/6\/R65\/64465164\/lvaf204.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/193\/6\/R65\/64465164\/lvaf204.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T11:17:13Z","timestamp":1764587833000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ejendo\/article\/193\/6\/R65\/8270768"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,1]]},"references-count":165,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,11,26]]}},"URL":"https:\/\/doi.org\/10.1093\/ejendo\/lvaf204","relation":{},"ISSN":["0804-4643","1479-683X"],"issn-type":[{"value":"0804-4643","type":"print"},{"value":"1479-683X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,12]]},"published":{"date-parts":[[2025,10,1]]}}}